°ü·Ã±â°ü ¼Ò½Ä

¹øÈ£ Á¦¸ñ µî·ÏÀÏ Ã·ºÎ Á¶È¸
865 [9/16] ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³] Ç׾Ͻžళ¹ß A-Z, Part 5. Antibody Drug Conjugates(ADC) 2022-09-02 ÆÄÀÏ 367
864 Á¦18Â÷ ¼¼°è³»½Ã°æº¹°­°æ¿Ü°ú »çÀüµî·Ï ¾È³» (~9/5) 2022-08-30 160
863 [»ï¼º¼­¿ïº´¿ø] Á¦1ȸ SMC PRO (Patient Reported Outcomes Symposium) °³ÃÖ ¾È³» (9/16) 2022-08-30 ÆÄÀÏ 210
862 [Çѱ¹°£´ãÃé¿Ü°úÇÐȸ] ½Ì±ÛÅäÇȽÉÆ÷Áö¿ò °³ÃÖ ¾È³» (16TH SINGLE TOPIC SYMPOSIUM (STS 2022)) 2022-08-16 ÆÄÀÏ 217
861 2022³â ±Û·Î¹ú ¹ÙÀÌ¿À ÄÜÆÛ·±½º 2022-08-10 ÆÄÀÏ 288
860 Á¦18Â÷ ¼¼°è³»½Ã°æº¹°­°æ¿Ü°ú Çмú´ëȸ ÃÊ·Ï Á¢¼ö ¾È³» (~8/12) 2022-08-08 219
859 2022³â ¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö(¿Â¶óÀÎ) °³ÃÖ ¾È³» 2022-08-10 314
858 [KSMO 2022] 15Â÷ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Çмú´ëȸ ¹× 2022 ±¹Á¦Çмú´ëȸ »çÀüµî·Ï ±â°£ ¿¬Àå 2022-08-03 246
857 [Çѱ¹º¸°ÇÀǷῬ±¸¿ø] ³ëÀÎ ¾ÏȯÀÚ Ä¡·á ÀÇ»ç°áÁ¤½Ã ÀÇ»çÀÇ °í·Á¿äÀÎ ¹× Àνĵµ Á¶»ç 2022-08-02 265
856 [Çѱ¹À¯ÀüüÇÐȸ] 2022 Á¦31ȸ KOGO Á¤±âÇмú´ëȸ °³ÃÖ ¾È³»(9/15-9/16) 2022-08-01 267
855 [±¹¸³¾Ï¼¾ÅÍ] 2022³â °øÀÍÀû¾Ï¿¬±¸»ç¾÷ ¸ñÀû°úÁ¦(¾ÏȯÀÚÅäÅ»Çコ ¿¬±¸»ç¾÷) ÀϺΠÀ§Å¹¿¬±¸°úÁ¦(ÀüÀÚµ¿ÀǸðÇü) °ø¸ð(¾È) 2022-07-25 446
854 2022³â ´ëÇÑÆó¾ÏÇÐȸ ±¹Á¦Çмú´ëȸ [KALC-IC 2022] 2022-07-18 277
853 2022³â "À¯¹æ¿Ü°ú ¾È¼¼Çö±³¼ö Á¤³â±â³ä" [Á¦1ȸ ¼­¿ï¾Æ»êº´¿ø À¯¹æ¾Ï ½ÉÆ÷Áö¾ö °³ÃÖ ¾È³» 8/27] 2022-07-14 ÆÄÀÏ 233
852 [ICBMT2022] 2022 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ µî·Ï ¾È³» 2022-07-11 238
851 ctDNA Liquid Biopsy WEBINAR °³ÃÖ ¾È³» (7/13) 2022-07-08 208
1 2 3 4 5 6 7 8 9 10 >